Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
duloxetine + acetaminophen
- Development stage
- Preclinical
- Lead developer
- Chattogram International Dental College
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Duloxetine + acetaminophen is a multimodal analgesic combination therapy being investigated for the management of post-endodontic pain. This combination leverages the synergistic effects of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), and acetaminophen, a central-acting analgesic and antipyretic. Duloxetine functions by increasing the synaptic concentrations of serotonin and norepinephrine, thereby enhancing descending inhibitory pain pathways. Acetaminophen provides analgesia primarily through the inhibition of cyclooxygenase enzymes and prostaglandin synthesis within the central nervous system. The combination is being evaluated by the Chattogram International Dental College as a preemptive treatment to mitigate both acute and chronic pain associated with dental procedures.
- Other names
- Duloxetine-AcetaminophenDuloxetine hydrochloride + acetaminophen
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)
Beyond the preview
Go deeper on duloxetine + acetaminophen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on duloxetine + acetaminophen.